1.A Clinical Study of Kawasaki Disease Complicating Coronary Aneurysm.
Chong Sung CHUNG ; Byung Yul LIM ; Sung Ho CHA ; Yong Mook CHOI ; Chang Il AHN
Journal of the Korean Pediatric Society 1989;32(9):1240-1247
No abstract available.
Coronary Aneurysm*
;
Mucocutaneous Lymph Node Syndrome*
2.Long term results of devega tricuspid annuloplasty.
Byung Yul KIM ; Wook Su AHN ; Yong HUR ; Jung Ho LEE ; Hoe Sung YU
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(11):827-832
No abstract available.
3.Complex cardiac Anomaly associated with the Digeorge syndrome.
Jun Ho MOON ; Wook Su AHN ; Yong HUR ; Byung Yul KIM ; Jung Ho LEE
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(11):886-889
No abstract available.
DiGeorge Syndrome*
4.The effect of aprotinin for hemostasis in open heart surgery.
Nin Su HONG ; Kyung Tai CHA ; Wook Su AHN ; Yong HUR ; Byung Yul KIM ; Jeong Ho LEE
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(10):749-752
No abstract available.
Aprotinin*
;
Heart*
;
Hemostasis*
;
Thoracic Surgery*
5.Considerations in relationship of open heart surgery and thyroid hormone changes.
Kyoung Tae CHA ; Min Su HONG ; Yong HUR ; Wook Su AHN ; Byung Yul KIM ; Jung Ho LEE ; Jin Hee HYUN
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(10):743-748
No abstract available.
Heart*
;
Thoracic Surgery*
;
Thyroid Gland*
6.The incidence of hypocalcemia, hypoglycemia and statistical levels of serum calcium and blood glucose in premature neonates.
Mi Young HONG ; Byung Yul LIM ; Chong Woo BAE ; Sung Ho CHA ; Sa Jun CHUNG ; Chang Il AHN
Korean Journal of Perinatology 1991;2(1):86-93
No abstract available.
Blood Glucose*
;
Calcium*
;
Humans
;
Hypocalcemia*
;
Hypoglycemia*
;
Incidence*
;
Infant, Newborn*
7.Clinical evaluation of lung cancer in patients younger than 40 years.
Jun Ho MOON ; Kyoung Tae CHA ; Yong HUR ; Wook Su AHN ; Byung Yul KIM ; Jung Ho LEE
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(11):861-865
No abstract available.
Humans
;
Lung Neoplasms*
;
Lung*
8.A clinical study of the tibial condylar fractures.
Jeong Gook SEO ; Byung Jik KIM ; Han Suk KO ; Young LIM ; Je Yul CHOI ; Eung Sun AHN
The Journal of the Korean Orthopaedic Association 1993;28(2):732-740
No abstract available.
9.Surgical treatment of primary cardiac tumor.
Kyoung Tae CHA ; Min Su HONG ; Byung Chul CHOI ; Seob LEE ; Hwan Kuk YOO ; Yong HUR ; Wook Su AHN ; Byung Yul KIM ; Jung Ho LEE ; Hoe Sung YU
The Korean Journal of Thoracic and Cardiovascular Surgery 1991;24(7):701-711
No abstract available.
Heart Neoplasms*
10.Serum eosinophil cationic protein in patient with bronchial asthma ; comparison with other markers of disease activity.
Ji Hoon YOO ; Jae Sun CHOI ; Chang Hyuk AHN ; Byung Hoon LEE ; Moon Jun NA ; Jae Yul KIM ; In Won PARK ; Byung Whui CHOI ; Sung Ho HUE
Journal of Asthma, Allergy and Clinical Immunology 1998;18(3):466-472
BACKGROUND: Serum eosinophil cationic protein(ECP) level has been proposed as a indirect marker of eosinophilic inflammation of the airway in bronchial asthma. OBJECTIVE: To evaluate serum ECP against indirect clinical markers of disease, we compared bronchial obstruction, bronchial hyperresponsiveness and peripheral blood eosinophil counts, total IgE with serum ECP levels in patients with bronchial asthma and normal controls. METHOD: Fourty-two patients with bronchial asthma and twenty-six normal controls were enrolled. Measurement were made by spirometry, inhalation challenge with methacholine, peripheral blood eosinophil counts, total IgE and FEIA(fluoroenzymatic immunoassay) of serum ECP RESULT: Serum ECP levels were significantly higher in asthmatic patients than normal controls(p<0.0,5). Serum ECP levels were correlated with peripheral blood eosinophil counts(p<0.01, r=0.544) and bronchial hyperresponsiveness(PC,)(p<0.01, r=-0.456) in patients with bronchial asthma. Serum ECP levels were correlated with degree of bronchial obstruction(FEV, % to predicted value, FEV1/FVC%) in total subjects, but not in asthmatic patients. CONCLUSION: Serum ECP level may be used as indicator of disease activity in bronchial asthma and be helpful in differentiation between normal person and asthmatic patients on simple serological method. Further studies on the changes of serum ECP levels according to disease course and therapeutic responses are needed.
Asthma*
;
Biomarkers
;
Eosinophil Cationic Protein*
;
Eosinophils
;
Humans
;
Immunoglobulin E
;
Inflammation
;
Inhalation
;
Methacholine Chloride
;
Spirometry